Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001493152-25-022066
Filing Date
2025-11-13
Accepted
2025-11-12 21:59:38
Documents
23

Document Format Files

Seq Description Document Type Size
1 S-3 forms-3.htm S-3 752435
2 EX-1.2 ex1-2.htm EX-1.2 377703
3 EX-5.1 ex5-1.htm EX-5.1 30756
4 EX-5.2 ex5-2.htm EX-5.2 10486
5 EX-23.1 ex23-1.htm EX-23.1 3270
6 EX-FILING FEES ex107.htm   iXBRL EX-FILING FEES 132463
7 GRAPHIC forms-3_001.jpg GRAPHIC 14384
8 GRAPHIC forms-3_002.jpg GRAPHIC 4062
9 GRAPHIC ex5-1_001.jpg GRAPHIC 4528
10 GRAPHIC ex5-1_002.jpg GRAPHIC 3317
11 GRAPHIC ex5-2_001.jpg GRAPHIC 4473
12 GRAPHIC ex5-2_002.jpg GRAPHIC 2840
  Complete submission text file 0001493152-25-022066.txt   1594372

Data Files

Seq Description Document Type Size
26 EXTRACTED XBRL INSTANCE DOCUMENT ex107_htm.xml XML 38864
Mailing Address 6801 N CAPITAL OF TEXAS HIGHWAY BUILDING 1; SUITE 300 AUSTIN TX 78731
Business Address 6801 N CAPITAL OF TEXAS HIGHWAY BUILDING 1; SUITE 300 AUSTIN TX 78731 512-501-2444
CASSAVA SCIENCES INC (Filer) CIK: 0001069530 (see all company filings)

EIN.: 911911336 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-291489 | Film No.: 251475163
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)